Patents by Inventor Gabriella Finizia

Gabriella Finizia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic carbapenem compounds
    Patent number: 6531466
    Abstract: A compound of formula (I), salts and metabolically labile esters thereof, wherein R represents optionally substituted aryl or heteroaryl group; A represents a propylene chain or A is a chain of 3 members one of which is selected from an oxygen or sulphur atom or the group NH or a substituted derivative thereof and the other two members are methylene groups, having antibacterial activity, processes for their preparation and to their use in medicine.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: March 11, 2003
    Assignee: GlaxoSmithKline SpA
    Inventors: Tino Rossi, Daniele Andreotti, Giovanna Tedesco, Luca Tarsi, Emiliangelo Ratti, Aldo Feriani, Domenica Antonia Pizzi, Giovanni Gaviraghi, Stefano Biondi, Gabriella Finizia
  • Tricyclic carbapenem compounds
    Publication number: 20010047094
    Abstract: A compound of formula (1), salts and metabolically labile esters thereof, wherein R represents optionally substituted aryl or heteroaryl group; A represents a propylene chain or A is a chain of 3 members one of which is selected from an oxygen or sulphur atom orthe group NH or a substituted derivative thereof and the other two members are methylene groups, having antibacterial activity, processes for their preparation and to their use in medicine.
    Type: Application
    Filed: February 13, 2001
    Publication date: November 29, 2001
    Applicant: Glaxo Wellcome SpA
    Inventors: Tino Rossi, Daniele Andreotti, Giovanna Tedesco, Luca Tarsi, Emiliangelo Ratti, Aldo Feriani, Domenica Antonia Pizzi, Giovari Gaviraghi, Stefano Biondi, Gabriella Finizia
  • 1,5-benzodiazepines useful as gastrinor CCK-antagonists
    Patent number: 5686449
    Abstract: The invention relates to compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof having gastrin and/or CCK-B antagonist activity.
    Type: Grant
    Filed: October 23, 1995
    Date of Patent: November 11, 1997
    Assignee: Glaxo Wellcome S.p.A.
    Inventors: Maria Elvira Tranquillini, Gabriella Finizia, Antonella Ursini